A New Horizon for Atopic Dermatitis Treatments: JAK Inhibitors

J Pers Med. 2023 Feb 22;13(3):384. doi: 10.3390/jpm13030384.

Abstract

The article entitled "Application of Janus Kinase Inhibitors in Atopic Dermatitis: An Updated Systematic Review and Meta-Analysis of Clinical Trials" that belongs to the Special Issue, " Personalized medicine in the field of inflammatory skin diseases", a collection of articles addressing the current critical issues in the pathogenesis and management of chronic inflammatory skin disorders, represents a valuable work that has contributed to elucidating the role of Janus kinase (JAK) inhibitors as a treatment option for atopic dermatitis (AD), as well as their safety profiles [...].

Publication types

  • Editorial